key: cord-0964392-a3lk2q02
authors: Kwong, A. S. F.; Pearson, R. M.; Adams, M. J.; Northstone, K.; Tilling, K.; Smith, D.; Fawns-Ritchie, C.; Bould, H.; Warne, N.; Zammit, S.; Gunnell, D. J.; Moran, P.; Micali, N.; Reichenberg, A.; Hickman, M.; Rai, D.; Haworth, S.; Campbell, A.; Altschul, D.; Flaig, R.; McIntosh, A. M.; Lawlor, D. A.; Porteous, D.; Timpson, N. J.
title: Mental health during the COVID-19 pandemic in two longitudinal UK population cohorts
date: 2020-06-18
journal: nan
DOI: 10.1101/2020.06.16.20133116
sha: 5f8c4c0f8fc50494c3683fa4fdc1906fa1a211ff
doc_id: 964392
cord_uid: a3lk2q02

Background: The impact of COVID-19 on mental health is unclear. Evidence from longitudinal studies with pre pandemic data are needed to address (1) how mental health has changed from pre-pandemic levels to during the COVID-19 pandemic and (2), whether there are groups at greater risk of poorer mental health during the pandemic? Methods: We used data from COVID-19 surveys (completed through April/May 2020), nested within two large longitudinal population cohorts with harmonised measures of mental health: two generations of the Avon Longitudinal Study of Parents and Children (ALPSAC): the index generation ALSPAC-G1 (n= 2850, mean age 28) and the parents generation ALSPAC-G0 (n= 3720, mean age = 59) and Generation Scotland: Scottish Family Health Study (GS, (n= 4233, mean age = 59), both with validated pre-pandemic measures of mental health and baseline factors. To answer question 1, we used ALSPAC-G1, which has identical mental health measures before and during the pandemic. Question 2 was addressed using both studies, using pre-pandemic and COVID-19 specific factors to explore associations with depression and anxiety in COVID-19. Findings: In ALSPAC-G1 there was evidence that anxiety and lower wellbeing, but not depression, had increased in COVID-19 from pre-pandemic assessments. The percentage of individuals with probable anxiety disorder was almost double during COVID-19: 24% (95% CI 23%, 26%) compared to pre-pandemic levels (13%, 95% CI 12%, 14%), with clinically relevant effect sizes. In both ALSPAC and GS, depression and anxiety were greater in younger populations, women, those with pre-existing mental and physical health conditions, those living alone and in socio-economic adversity. We did not detect evidence for elevated risk in key workers or health care workers. Interpretation: These results suggest increases in anxiety and lower wellbeing that may be related to the COVID-19 pandemic and/or its management, particularly in young people. This research highlights that specific groups may be disproportionally at risk of elevated levels of depression and anxiety during COVID-19 and supports recent calls for increasing funds for mental health services. Funding: The UK Medical Research Council (MRC), the Wellcome Trust and University of Bristol.

The coronavirus disease 2019 pandemic has resulted in radical changes to societies 62 globally. As the number of infected cases and deaths increased, many countries adopted public health 63 measures including lockdown, social distancing and self-isolation. While such measures may be 64 important for reducing transmission, they may also have a profound effect on mental health, [1-3] 65 However, the extent to which mental health is affected by COVID-19 and its management, and who is 66 at greatest risk, is unknown. Longitudinal studies with pre-pandemic data are vital for addressing this. 67

Although not directly comparable to COVID-19, evidence from previous viral outbreaks provide 68 relevant information. The Severe Acute Respiratory Syndrome epidemic (SARS) resulted in public 69 health mitigation measures in some countries and was associated with an increase (from pre-pandemic 70 levels) in anxiety, depression, suicide and post-traumatic stress disorder during and beyond the 71 conclusion of the outbreak for survivors of the virus, [4] [5] [6] and the unexposed public. [7, 8] Compared 72 to SARS, the COVID-19 pandemic is greater in scale, resulting in more infections and deaths as well 73 as more extreme mitigation methods. The consequences for mental health resulting from the COVID-74 19 pandemic could therefore be substantial. [1, 9] Unlike previous outbreaks, COVID-19 is 75 widespread meaning the impact on global economy and health could be unprecedented. 76

Several rapid cross-sectional surveys during the COVID-19 pandemic have suggested a higher 77 prevalence of anxiety, depression, [10, 11] and low wellbeing compared to historical estimates. [12, 78 13] However, these studies lack pre-pandemic information in the same people, reporting symptoms 79 during and before the pandemic. This precludes accurate assessment of changes in mental health. 80

Furthermore, selection (due to mental health influencing who respond to surveys) and reporting bias 81 (those who perceive depression and anxiety as higher or are more likely to report symptoms when 82 they feel there is a 'valid' reason) could threaten the validity of results from cross-sectional surveys. 83

[14] There is a need for data from longitudinal designs with well-characterized sampling frames and 84 pre-pandemic data. Such studies can more accurately identify changing patterns of mental health and 85 identify risk groups, informing development of interventions for those at heightened risk and aiding 86 policy decisions regarding the immediate management of COVID-19, including plans for easing 87 restrictions, as well as for the longer-term care for groups whose mental health may be particularly 88 affected. [1, 9] 89

The COVID-19 pandemic is likely to exacerbate existing social and psychological inequalities. [15] 90

Previous studies have identified several groups who may be at greater risk of poorer mental health 91 during COVID-19, including younger people, women, healthcare workers and those with poorer 92 financial or living circumstances. [10, 11, 13, 16] Parents with school-aged children, individuals at 93 risk of physical and emotional abuse and those at greater physical risk of COVID-19 (older age, and 94 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 those with chronic conditions such as, asthma, obesity, diabetes) may also be at heightened risk of 95 poorer mental health. 96

We used data from two large longitudinal cohort studies, both with rich pre-pandemic measures of 97 mental health, to address (1) how has mental health changed from pre-pandemic levels to the COVID-98 19 pandemic and (2) are there groups at greater risk of poorer mental health during the pandemic? The 99 first of these is important for exploring the impact of COVID-19 and its management on mental health 100 and potential increases in poor mental health long-term. The second is important for targeting of 101 mental health care needs now and during any subsequent waves and for identifying groups who might 102 benefit from long-term monitoring after the pandemic. 103 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 Methods 104

We selected two comparable cohort studies to allow replication in different regions of the UK, but 106 with similar timings of mental health measures before and during the COVID-19 pandemic. 107

The Avon Longitudinal Study of Parents and Children (ALSPAC) is an ongoing longitudinal 108 population-based study that recruited pregnant women residing in Avon in the south-west of England 109 with expected delivery dates between 1 st April 1991 and 31 st December 1992. [17, 18] This study uses data from 3720 ALSPAC-G0 and 2973 ALSPAC-G1 who completed an online 122 questionnaire about the impact and consequences of the COVID-19 pandemic between 9 th April and 123 14 th May 2020 (see, appendix figure 1 and figure 2) [22] . In GS, data were from 4,233 individuals 124 who completed a similar online COVID-19 questionnaire between 17 th April and 17 th May 2020 (see, 125 appendix figure 3). Lockdown was announced in the UK on the 24 th March. 126

The measures used in the COVID-19 survey examine symptoms in the preceding 2 weeks, thus 128 represent mental health in the immediate period following lockdown. Depressive symptoms in 129 disorder symptoms. Scores range between 0-21 with higher scores indicting higher anxiety symptoms. 137

Mental wellbeing in ALSPAC and GS was also measured using the same instrument, the Short 138 Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS), [26] a 7-item instrument which 139 measures positive mental wellbeing. Scores range between 7-35, with higher scores indicating better 140 mental wellbeing. These measures have recommended cut-offs for examining the proportion of 141 individuals with probable depression (≥11 on SMFQ and ≥10 on PHQ-9), generalised anxiety 142 disorder (≥10 on GAD-7) and poor mental wellbeing (≤17 on SWEMWBS), with good sensitivity and 143 specificity for identifying clinical disorder using validated interviews and instruments and widely 144 used in primary care and clinical trials (see appendix methods). Herein we refer to depressive 145 symptoms as depression and anxiety symptoms as anxiety. 146

Baseline depression and anxiety were assessed in ALSPAC and GS prior to the COVID-19 pandemic. 148

In ALSPAC-G1, baseline mental wellbeing was also assessed. These measures are described in Table  149 1, alongside information on the baseline factors that may predict poorer mental health in We refer to these as factors to make it clear that we are not assuming they are causal but could be 151 useful for identifying vulnerable groups. The factors we explored included demographic and social 152 information such as sex, age, educational background, financial circumstances, deprivation status, 153 victimisation and being a parent with school-aged children. Additional factors included pre-existing 154 mental health conditions, substance misuse, genetic risk for depression, cognitive styles, personality 155 traits and difficulties accessing mental health information. Due to differences in data collection, 156 several factors are only assessed in either ALSPAC or GS. We also examined associations with 157 several COVID-19 specific factors that may be valuable predictors of adverse mental health, 158 including obesity, asthma, infection status, isolation status, living alone, access to a garden, health-159 care worker and key worker status. Detailed information regarding the descriptions and timing of 160 these measures including availability and how measures were harmonised, are given in the appendix 161 method section. 162

Analysis was conducted in StataSE (version 15). Initially, we described the prevalence of mental 164 health outcomes during the COVID-19 pandemic in all cohorts. To answer our first research question, 165

we used ALSPAC-G1 to examine how mental health changed from baseline (pre-pandemic) to 166 COVID-19 levels. This analysis was only possible in ALSPAC-G1 who had identical mental health 167 measures at baseline and during . 168

To answer our second research question, we examined associations between factors (both baseline 169 measures and those specific to and measured during the pandemic) and COVID-19 depression and 170 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10. 1101 anxiety. Analysis was conducted separately for all cohorts, adjusting for sex, age and the date they 171 completed the COVID-19 questionnaire (to account for heterogeneity in response times). In 172 ALSPAC-G0 and GS, we used alternative measures capturing the same construct to account for pre-173 existing depression and anxiety (the EPDS in ALSPAC-G and the GHQ-28 in GS). Wellbeing was 174 not assessed at baseline in ALSPAC-G1 or GS, therefore we restrict this analysis to depression and 175 anxiety only. The results for question two can be interpreted as identifying factors associated with 176 depression and anxiety, that are not driven by past symptoms of either disorder (as they are adjusted 177 for in the model). Continuous COVID-19 and baseline depression and anxiety were standardised to 178 create Z scores allowing comparison of effect sizes across outcomes and cohorts. 179

Our eligible samples were defined as those who completed at least one mental health measure during 181 the COVID-19 surveys: ALSPAC-G0 n= 3579, ALSPAC-G1 n= 2872 and GS n =4208 (appendix 182 figures 1-3, appendix table 1). We imputed incomplete baseline depression, anxiety and factors using 183 earlier or concurrent information up to the eligible samples, using multiple imputation by chained 184 equations to generate 50 imputed datasets.

[27] Full information on the proportion of missing baseline 185 data in each cohort are given in the appendix table 2-4, the majority (>80%) of participants had more 186 than 50% of complete baseline data (i.e., all factors and baseline mental health) with less than 1% 187 only having information on only 1 or 2 baseline variables. Analyses on multiple imputed datasets uses 188 rich pre-pandemic data available to plausibly meet the assumption that data are missing at random, 189

i.e., conditional on observed information. Whereas, complete case analyses assume that missingness is 190 not related to the outcome conditional on the exposure and any covariables. Given that we have 191 demonstrated that the missing baseline data was associated with lower education and sex (appendix 192 table 1) it is likely that the complete case sample is biased and thus we primarily present imputed 193 estimates which also increase power. Details regarding imputation are fully described in the appendix. 194

In sensitivity analysis, we also examined depression and anxiety using the 'proportion-above-196 threshold' in logistic regressions rather than continuous scores as outcomes, analysed varying ages for 197 baseline measures and estimated 'counterfactual' trajectories for the mental health measures to 198 highlight differences in the observed compared to predicted trajectories. 199

The funders of the study had no role in the study design, data collection, data analysis, data 201 interpretation, or writing of this manuscript. The corresponding author had full access to the data in 202 the study and had final responsibility for the decision to submit for publication. 203 204 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133116 doi: medRxiv preprint

Data on COVID-19 mental health outcomes in ALSPAC-G0 were available for 3579 people (mean 206 age: 58.67 years, SD: 4.82), for ALSPAC-G1, 2872 people (mean age: 27.61 years, SD: 0.54 ) and GS 207 4208 people (mean age: 59.24 years, SD: 12.03), see appendix figures 1-3, appendix table 1. 208

The prevalence of probable depression decreased with age in ALSPAC and GS. Similar results were 210 observed for probable anxiety and low wellbeing ( Figure 1 ). 211

The percentage of individuals with probable depression was lower, 18.14 % (16.76, 19.61), in 213 COVID, compared to 24.35 % (23.04, 25.70) at the most recent baseline. The percentage of people 214 with probable anxiety disorder was almost double during COVID-19 :24% (95% CI 23% ,26%) 215 compared to pre-pandemic levels (13%, 95% CI 12 %, 14%) and for lower wellbeing :13, (95% CI 12 216 to 14%%) compared to 8% (95% CI 7 to 9%) (Figure 2, appendix table 5 and 6). When examining 217 continuous measures of mental health, there was a mean difference in SMFQ score of -0.60 (95% CI: 218 -0.84, -0.37), 1.36 (95% CI: 1.10, 1.61) for GAD-7 and 2.45 (95% CI 2.25 to 2.65) for SWEMWBS, 219 when comparing the most recent baseline to COVID-19. To give a summary of magnitude, these 220 estimates represent a 0.11, 0.26 and 0.51 standardised effect difference respectively (appendix table 221 7). Item level differences for each measure are shown in figure 3 . 222 Table 2 and figures 4 and 5 show the associations between baseline and COVID-19 specific factors 224 and depression and anxiety, with adjustment for baseline depression and anxiety symptoms (measured 225 on a continuous scale in standard deviation units for ease of comparison between cohorts and 226 outcomes). 227

A reported or suspected COVID-19 infection was associated with higher depression and anxiety in 228 ALSPAC-G0, but only higher depression in GS with no associations observed in ALSPAC-G1. 229

Living alone during the pandemic was associated with higher depression, but not with higher anxiety 230 in ALSPAC and GS. No access to a garden was associated with higher depression in all cohorts and 231 greater anxiety in GS. ALSPAC-G0 and ALSPAC-G1 participants who reported that they had self-232 isolated had higher depression and anxiety, but it was not possible to test this in GS. Key workers (of 233 any kind) and health care workers were not associated with higher depression or anxiety. There was 234 an association between being a key worker and having lower depression in ALSPAC-G1, but this was 235 not replicated in ALSPAC-G1 or GS. 236 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10. 1101 For pre-pandemic factors, focusing on replicated results (those showing consistent associations in at 237 least two cohorts), we found evidence for higher depression and anxiety in women, those with 238 financial problems, lower educational backgrounds, lower income, living in a more deprived area, 239 those with obesity. A positive association of being a parent of a young child with higher anxiety in 240 ALSPAC-G1 did not replicate in GS and was not associated with depression in either cohort. 241

Reporting an emotionally abusive partner was only available in ALSPAC-G0 but was positively 242 associated with both greater depression and anxiety. Asthma had positive associations with higher 243 anxiety in ALSPAC-G1 and GS but was not associated with depression in both cohorts. 244

There were strong and replicated associations between several pre-existing mental health problems 245 and higher depression and anxiety, including a history of major depression disorder, psychosis-like 246 symptoms, negative cognition, neuroticism, and a history of self-harm. The depression polygenic risk 247 score was also positively associated with depression and anxiety in ALSPAC-G0 and GS (though not 248 in ALSPAC-G1). 249

Depression and anxiety were higher in ALSPAC-G1 in those who reported generalised anxiety 250 disorder, OCD traits, disordered eating, autistic traits, and difficulty accessing mental health services, 251 but these outcomes were not available in ALSPAC-G1 or GS and so could not be replicated. 252

Personality disorder traits were associated only with higher anxiety in G1 but both anxiety and 253 depression ALSPAC-G0. A history of alcohol abuse was associated with increased depression in 254 ALSAPC-G1 and anxiety in both ALSAPC-G0 and ALSPAC-G1, but not replicated in GS. By 255 contrast smoking was associated with increased depression and anxiety in both ALSPAC-G0 and GS 256 but not ALSPAC-G1. 257

Results were similar using complete case analysis (appendix table 8), adjusting for educational 258 background with imputation (appendix table 9), using different timings of baseline depression and 259 anxiety (appendix tables 10 and 11) and examining binary outcomes (appendix table 12). 260 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133116 doi: medRxiv preprint

We report a population-based longitudinal study to track changes in depression and anxiety from 262 before to during the COVID-19 pandemic, providing potentially important new information for policy 263 planning. Although we found no clear evidence that depression has changed during COVID-19 from 264 pre-pandemic waves in ALSPAC-G1, there was strong observational evidence that anxiety and lower 265 wellbeing were higher during COVID-19 compared to pre-pandemic levels. Approximately twice as 266 many young adults experienced probable anxiety disorder and low wellbeing during the pandemic 267 The uncertainty and sudden change to everyday life, as well as concerns over health, may explain why 276 anxiety, rather than depression, has initially risen. The apparent rise in younger ages may reflect the 277 impact of mitigation measures (i.e., lockdown and social distancing) rather than a risk of COVID-19 278 infection (which may be higher in older populations). Furthermore, depression usually relates to 279 feelings of loss, whilst anxiety relates to threat, as the majority of participants may not yet have lost 280

anything (e.g., death of loved one, loss of job) this may also explain why depression has currently 281 remained stable. There is also evidence that anxiety changes more rapidly than depression following 282 treatment. [28] . What separates this pandemic from historical outbreaks, is the global impact. This, 283 alongside the community spirit, may have been protective against the self-blame and guilt intrinsic to 284 depression.

[31] Indeed, depression items that were lower in the pandemic, as compared to previous 285 waves, related to feelings of self-blame. As social inequalities become apparent and threat of loss 286 becomes actual loss, this may change. The current survey was in UK spring, whereas previous 287 ALSPAC-G1 waves were predominantly completed in winter. Seasonal trends suggest that depression 288 and anxiety scores are approximately 1-2 points (0.1 SD) lower and 5% less of individuals are above 289 thresholds in spring than winter, [32] which may explain lower depression scores. 290

Irrespective of the overall change in depression and anxiety in each cohort, several sociodemographic, 291 psychological, physical and COVID-19 factors were associated with greater depression and anxiety 292 during COVID-19. A reported or suspected COVID-19 infection was a factor for higher depression 293 and anxiety in ALSPAC-G0 and GS, possibly reflecting the high perceived risk to physical health in 294 older ages. This supports previous research, [2] but must be interpreted with caution because COVID-295 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10. 1101 19 status here largely includes participants' perception that they have COVID-19. Therefore, it maybe 296 that those with pre-existing depression and anxiety are more likely to perceive that their symptoms are 297 COVID-19 rather than other conditions. There was consistent evidence in participants from ALSPAC 298 and GS that health risk groups linked to COVID-19, such as those with obesity and to some extent 299 asthma, had higher depression and anxiety during COVID-19, potentially reflecting concerns 300 regarding perceived risk of infection or the impact of more stringent social distancing. There was no 301 evidence that key workers or health workers were at greater risk of depression or anxiety, suggesting 302 these groups are not yet experiencing difficulties. This may reflect the heterogenous group of 303 occupations included in this group, but whilst we observed no initial change in these groups, as the 304 situation continues, frontline health care workers may become at risk of PTSD. 305

Those reporting self-isolation were at higher risk of both anxiety and depression but living alone was 306 consistently associated with greater depression only. The manifestation of depression rather than 307 anxiety for those living alone may relate to loneliness which is amplified with physical contact 308 restricted to within households, again reflecting depression being related to absence and loss rather 309 than threat. Whereas, self-isolation (which in this context is related to having symptoms) may be 310 linked to anxiety through associated threat of the virus. Parents of young children were more anxious 311 in ALSPAC, which may reflect stress related to the sudden change in childcare provision. Financial 312 problems, lower income and deprivation were associated with greater risk of depression and anxiety 313 in ALSPAC-G0 and GS. Financial problems, but not lower income, was also associated with higher There are several limitations to this work. Firstly, as the pandemic is a universal exposure, it is 325 difficult to attribute factors to the impact of the COVID-19 pandemic specifically, with many factors 326 likely to show an association with later depression and anxiety at any time.

[31] However, using 327 longitudinal data and methods, we were able to demonstrate that anxiety and lower wellbeing were 328 worse during COVID-19 than expected, given the comparison between baseline and pandemic 329 assessments, so it is unlikely these effects are not related to COVID-19. Secondly, there were 330 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133116 doi: medRxiv preprint heterogeneous measurements of mental health in COVID-19 specific surveys and baseline, as well as 331 differences in the length of follow up across cohorts. This poses a challenge in inferring strong 332 conclusions on change and specificity of findings to generations or cohorts. However, several 333 sensitivity analyses in both cohorts and exploring different baselines reached similar conclusions. 334 Thirdly, we were only able to assess change over the pandemic in ALSPAC-G1. Therefore, our 335 inferences may only be relevant to young adult populations. However, given the replication between 336 younger ages and higher rates of depression and anxiety, it is likely these effects will be observed in 337 other studies. Fourthly, although we were able to use existing data such as educational background to 338 predict baseline missingness and use such variables in imputation models, we did not impute further 339 than the sample with complete COVID-19 survey data, given that data was unique. Thus, there may 340 be issues with generalisability as respondents were more likely to be female and from higher 341 educational backgrounds than previous ALSPAC and GS surveys. Furthermore, the meaning and 342 interpretation of depression, anxiety and wellbeing may vary during pandemics, for example, some 343 level of tension and fear may be adaptive and appropriate. However, our item level analysis revealed 344 that all anxiety and mental wellbeing items were worse during COVID-19, implying a global decrease 345 in these aspects of mood, not just for specific components. Finally, we compared multiple factors and 346 therefore some statistical associations may have occurred as a result of chance. However, for most 347 factors, there was evidence for replication of findings across multiple cohorts, suggesting that 348 'chance' findings are less likely. 349

Future work is needed to understand the mechanisms and complex interplay between baseline and 350 COVID-19 specific factors and mental health during the COVID-19 pandemic. Future research should 351 also consider how changes in anxiety might influence public behaviour through contact patterns and 352 compliance with policies. Depression and anxiety, along with associated impairment should continue 353 to be carefully monitored to forecast the long-term impact of this crisis. This can help ensure that 354 future policies consider optimal preservation of both physical and mental health. 355 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 Contributors 356 ASFK, RMP, MJA, KN, KT, AMM, DAL, DP and NJT contributed to the conception and design of 357 the study. ASFK, RMP, MJA, KN, AC, SH, CFR, DA, RF, DS, DP and NJT contributed to the 358 organisation of the conduct of the study. ASFK carried out the study (including acquisition of data). 359 ASFK and MJA analysed the data. ASFK and RMP drafted the initial output. All authors contributed 360 to the interpretation of data. All authors have read and approved the final version of the manuscript. 361 ASFK will serve as guarantor for the contents of the paper. 362

We declare no competing interests. 364

ALSPAC data is available to researchers through an online proposal system. Information regarding 366 access can be found on the ALSPAC website (http://www.bristol.ac.uk/media-367 library/sites/alspac/documents/researchers/data-access/ALSPAC_Access_Policy.pdf). 368

Committee (access@generationscotland.org). The managed access process ensures that approval is 370 granted only to research which comes under the terms of participant consent. Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the 374 ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). 375

We are extremely grateful to all the families who took part in this study, the midwives for their help in 376 recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory 377 technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. Part Trust and the University of Bristol. Generation Scotland received core support from the Chief 388 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . Table 2 . Associations between baseline risk factors and depression and anxiety using the imputed samples. Results are standardised estimates for depression and anxiety, adjusted for prior depression or anxiety, sex, age and when the COVID-19 questionnaire was completed. *Indicates the % of individuals with caseness for ALSPAC-G0 / ALSPAC-G1 / GS respectively. **Indicates a continuous scale was used so no proportions are given. ***Indicates this was on complete case analysis only. MDD: major depressive disorder; GAD: generalised anxiety disorder; OCD: obsessive compulsive disorder; PRS: polygenic risk score. Figure 1A (top left) shows probable depression, probable generalised anxiety disorder (GAD) and lower wellbeing by each cohort. Figure 1B (top right) shows probable depression by age groups assessed using the SMFQ in ALSPAC and PHQ-9 in GS. Figure 1C (bottom left) shows probable GAD by age groups assessed by the GAD-7. Figure 1D shows lower wellbeing by age groups assessed by the SWEMWBS. Note, ALSPAC-G1 (n=2812) were categorised as 18-40, even though the max age of this cohort is 29 years. Age in ALSPAC-G0 was split by the following: Age 40-49 (n=89), Age 50-59 (n=2105), Age 60-69 (n=1455) and Age 70+ (n=71). In GS, Age was split by the following: Age 18-40 (n=356), Age 40-49 (n=534), Age 50-59 (n=964), Age 60-69 (n=1526) and Age 70+ (n=853).

Changes in mental health across baseline (pre-pandemic) to COVID-19 in ALSPAC-G1. Figure 2A (top left) shows changes in probable depression as assessed by the SMFQ. Figure 2B (top right) shows changes in probable GAD assessed by the GAD-7 at age 22 and CISR GAD at ages 18 and 24. Figure  2C (bottom left) shows changes in lower wellbeing assessed by the SWEMWBS. Figure 3A (top left) shows how items of the SMFQ (depression) vary from the most recent baseline (Age 26) to COVID-19. Figure 3B (top right) shows how items of the GAD-7 (anxiety) vary from the most recent baseline (Age 22) to COVID-19. Figure 3C (bottom left) shows high items from the SWEMWBS (mental wellbeing) vary from the most recent baseline (Age 24) to COVID-19.

Associations between baseline and COVID-19 factors and depression during COVID-19, adjusted for baseline depression, sex, age and when the COVID-19 questionnaire was completed, using imputed data. Estimates refer to a standard deviation increase in depression, over and above depression at baseline. Figure 4A (top left) shows associations between baseline sociodemographic factors and depression during COVID-19. Figure 4B (top right) shows associations between baseline physical health and COVID-19 specific factors and depression during COVID-19. Figure 4C (bottom left) and Figure 4D (bottom right) shows associations between baseline mental health factors and depression during COVID-19.

Associations between baseline and COVID-19 factors and anxiety during COVID-19, adjusted for baseline anxiety, sex, age and when the COVID-19 questionnaire was completed, using imputed data. Estimates refer to a standard deviation increase in anxiety, over and above anxiety at baseline. Figure  4A (top left) shows associations between baseline sociodemographic factors and anxiety during COVID-19. Figure 4B (top right) shows associations between baseline physical health and COVID-19 specific factors and anxiety during COVID-19. Figure 4C (bottom left) and Figure 4D (bottom right) shows associations between baseline mental health factors and anxiety during COVID-19. 

Multidisciplinary research priorities for the COVID-19 pandemic: a call for 404 action for mental health science. The Lancet Psychiatry

Psychiatric and neuropsychiatric presentations associated with severe 406 coronavirus infections: a systematic review and meta-analysis with comparison to the 407 COVID-19 pandemic. The Lancet Psychiatry

The psychological impact of quarantine and how to reduce it: rapid review 409 of the evidence. The Lancet

Mental Morbities and Chronic Fatigue in Severe Acute Respiratory 411 Syndrome Survivors: Long-term Follow-up

A revisit on older adults suicides and Severe Acute 413 Respiratory Syndrome (SARS) epidemic in Hong Kong

Long-term psychiatric morbidities among SARS survivors. Gen Hosp 416 Psychiatry

Avoidance behaviors and negative psychological responses in the general 418 population in the initial stage of the H1N1 pandemic in Hong Kong

Psychosocial Impact of SARS. Emerging 421 Infectious Diseases

Timely mental health care for the 2019 novel coronavirus outbreak is 423 urgently needed. The Lancet Psychiatry

A nationwide survey of psychological distress among Chinese people in the 425 COVID-19 epidemic: implications and policy recommendations

Factors Associated With Mental Health Outcomes Among Health Care Workers 428 Exposed to Coronavirus Disease

COVID-19 Social Study -Results Release 10

Says who? The significance of sampling in mental health surveys during 435 COVID-19. The Lancet Psychiatry

Suicide risk and prevention during the COVID-19 pandemic. The Lancet 437 Psychiatry

How are adversities during COVID-19 affecting 439 mental health? Differential associations for worries and experiences and implications for 440 policy. medRxiv

Cohort Profile: the 'children of the 90s'--the index offspring of the Avon 442 Longitudinal Study of Parents and Children

Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC 444 mothers cohort

The Avon Longitudinal Study of Parents and Children (ALSPAC): an 446 update on the enrolled sample of index children in 2019

Cohort Profile: Generation Scotland: Scottish Family Health Study 448 (GS:SFHS). The study, its participants and their potential for genetic research on health and 449 illness

 Tables and figures   ALSPAC-G0  ALSPAC-